Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
about
Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review.miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a.Inhibition of Epac2 Attenuates Neural Cell Apoptosis and Improves Neurological Deficits in a Rat Model of Traumatic Brain Injury.Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation
P2860
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
@en
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
@nl
type
label
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
@en
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
@nl
prefLabel
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
@en
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
@nl
P2093
P2860
P356
P1433
P1476
Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.
@en
P2093
P2860
P304
P356
10.1002/CAM4.946
P407
P577
2016-11-04T00:00:00Z